Rejected from Nature Methods? The 7 Best Journals to Submit Next

• "The improvement over existing methods is incremental.": Your method is better than what exists, but not transformatively so. This is the most common desk rejection at Nature Methods. The tool works, but existing alternatives can accomplish roughly the same thing.

• "The scope is too specialized.": Your method solves a real problem, but only within one subdiscipline. A new technique for analyzing C. elegans behavior, for example, is too narrow for Nature Methods' general life science audience, even if it's the best tool in that niche.

• "The benchmarking is insufficient.": You claimed your method outperforms alternatives but didn't provide rigorous head-to-head comparisons using standardized datasets or established benchmarks. Nature Methods reviewers expect thorough performance validation.

• "The biological application doesn't demonstrate the method's value.": You built a tool and showed it works on synthetic data or well-studied systems. Nature Methods wants to see the method applied to a real biological question where it reveals something new.

Nature Methods editors can transfer manuscripts to:

• Nature Communications (IF ~16) - Broad scope, any method with scientific merit- Nature Biotechnology (IF ~33) - If the technology-biology combination is strong- Communications Biology (IF ~5) - Solid biological methods- Nature Protocols (IF ~13) - Detailed method protocols (different format)- Scientific Reports (IF ~4) - Sound methodology, broad acceptanceNature Communications is the most common transfer destination for papers that are clearly good methods but don't meet Nature Methods' novelty threshold. If you receive a transfer offer, consider it seriously.

Before choosing your next journal, a Nature Methods manuscript fit check can tell you whether the issue was scope or something more fundamental to address first.

• Experimental method rejected for "incremental improvement"?: Consider whether the biological application is strong enough for Nature Biotechnology, or whether the method should go to a discipline-specific journal (e.g., a microscopy method to Journal of Microscopy, a protein method to Journal of Proteome Research).

• Computational tool rejected for "narrow scope"?: Bioinformatics is the natural home for specialized algorithms. Genome Biology for broader genomics tools. NAR for databases and web servers.

• Method rejected for "insufficient benchmarking"?: Add benchmarking before resubmitting anywhere. Every methods journal will ask for performance comparisons. Address this before choosing a new target.

• Method with a strong biological result rejected for "the biology is more interesting than the method"?: Submit to a biology journal in the relevant field (Nature Genetics for genomics discoveries, Nature Cell Biology for cell biology findings, etc.).

• Strengthen benchmarking: Every methods journal expects rigorous comparisons against existing tools. Use standardized benchmark datasets. Be honest about failure modes. Show both where your method excels and where it doesn't.

• Add usability information: Provide code availability, documentation, and tutorials. A method nobody else can reproduce or use isn't publishable anywhere. Nature Methods, Genome Biology, and Bioinformatics all require code and data availability.

• Sharpen the novelty claim: If Nature Methods said the advance was incremental, you need to either add new capabilities or reframe the contribution for a journal that values refinement and validation (like Bioinformatics or NAR).

Nature Biotechnology is the flip side of Nature Methods. Where Nature Methods values the method itself, Nature Biotechnology values the combination of a new technology and what it reveals biologically. If Nature Methods rejected your paper because "the biological application is more compelling than the methodological advance," Nature Biotechnology might see it differently. The caveat: Nature Biotechnology wants both the technology and the application to be novel. If your method is a minor improvement applied to an important biological question, neither journal will be satisfied.

Best for: Technology-driven biological discoveries where the method and the biology are both strong. Papers where Nature Methods said the method alone wasn't novel enough.

Genome Biology is the leading journal for computational biology and genomics method development. If your paper involves a bioinformatics algorithm, genomic analysis pipeline, single-cell analysis tool, or sequencing technology, Genome Biology reaches exactly the right audience. The journal has a strong tradition of publishing benchmarking studies and community resources. If your paper includes systematic comparisons of existing methods alongside your new one, Genome Biology values that community service. The acceptance rate (~15%) is more accessible than Nature Methods.

Best for: Computational biology methods, genomics tools, benchmarking studies, analysis pipelines, community data resources.

NAR is uniquely valuable for DNA/RNA methods, databases, and web servers. The annual web server issue has a high acceptance rate (~40%), making it the fastest path to publication for computational tools. Research articles on molecular biology methods are more selective (~20%) but still more accessible than Nature Methods. NAR's readership includes molecular biologists, bioinformaticians, and genomics researchers. If your method involves sequence analysis, gene editing, or molecular biology techniques, NAR ensures it reaches practitioners who will use it.

Best for: Molecular biology methods, sequencing tools, gene editing techniques, databases, web-based analysis tools.

Bioinformatics is the established home for computational methods in biology. The journal publishes algorithms, statistical methods, software tools, and analysis frameworks. Its "Application Notes" format is particularly useful for standalone software tools that don't require extensive biological validation. The acceptance rate (~14%) is realistic, and reviewers are computational biologists who understand the technical details of algorithm development. If Nature Methods rejected your computational method for being "too specialized," Bioinformatics will value the technical contribution on its own merits.

Best for: Algorithm development, statistical methods for biological data, software tools, computational pipelines.

For methods papers that are clearly good science but don't meet Nature Methods' specific novelty or scope requirements, Nature Communications provides a broad-scope home within the same publisher. The ~8% acceptance Nature Communications is common. Your referee reports transfer with the manuscript, and the editor already knows Nature Methods found merit in the work.

Best for: Solid methods papers that didn't quite meet Nature Methods' bar. Interdisciplinary methods. Papers where the method and application are both good but neither is individually transformative.

Cell Systems publishes methods focused on understanding biological systems at scale. The journal is particularly receptive to multi-omics integration methods, network analysis tools, and computational approaches to complex biological questions. If your method addresses systems-level questions (how do multiple pathways interact? How does cellular heterogeneity emerge?), Cell Systems values that systems perspective. The journal is part of Cell Press and benefits from thorough, constructive peer review.

Best for: Systems biology methods, multi-omics integration, network analysis, single-cell computational methods.

For methods at the chemistry-biology interface, Analytical Chemistry is one of the top venues. The journal publishes mass spectrometry methods, chromatography techniques, biosensor development, and analytical platforms applied to biological samples. If Nature Methods rejected your analytical method for being "too chemical" or "too applied," Analytical Chemistry will value the technical contribution. The journal's ACS readership includes both chemistry and biology researchers.

Best for: Mass spectrometry methods, metabolomics tools, biosensor development, analytical platforms for biological samples.

• How to choose a journal for your paper
• Signs your paper is not ready to submit
• What pre-submission peer review includes

Before you resubmit, run your manuscript through a manuscript scope and readiness check to check fit, structure, and editorial risk before the next submission.

In our pre-submission review work with manuscripts targeting Nature Methods, four patterns generate the most consistent desk rejections worth knowing before resubmission.

Incremental methodological improvement over existing approaches. Nature Methods publishes tools that transform how biological research is done, not tools that improve on current methods by 20-30% in benchmark performance. We see this failure as the most common pattern in Nature Methods desk rejections we review: papers demonstrating a genuinely better method, with rigorous performance validation, where existing alternatives can accomplish the same experimental goal with acceptable trade-offs. In our review of Nature Methods submissions, we find that editors consistently require the method to enable research that was previously impossible, not just to do existing research faster or with fewer cells.

Scope too specialized for the general life sciences readership. Nature Methods serves cell biologists, geneticists, neuroscientists, and structural biologists as a single audience. Methods solving a problem that matters only within one niche subdiscipline consistently fail the desk breadth test. A new algorithm for reconstructing C. elegans connectomes is genuinely valuable but too specialized for Nature Methods' editorial scope.

Insufficient benchmarking against established alternatives. We see this pattern in methods submissions we review for Nature Methods present performance claims without rigorous head-to-head comparisons using standardized datasets or community benchmarks. Nature Methods editors and reviewers expect thorough performance validation against every relevant alternative, using datasets the field recognizes as authoritative, before the claims can be accepted.

Strong biological result with the method serving as enabler rather than contribution. When reading a Nature Methods submission, editors ask whether the method is the hero of the paper. Papers where a new or adapted technique reveals compelling biology but the technique itself is not broadly applicable to other biological questions are redirected to biology journals. The method must be the advance, not the biology enabled by it.

SciRev community data for Nature Methods confirms desk rejections typically arrive within days, with post-review first decisions in 6-8 weeks, consistent with the Nature Portfolio editorial cadence.

Think twice before submitting to Nature Biotechnology or Nature Communications if the rejection identified insufficient benchmarking; those journals also require rigorous performance comparisons.